Planned Phase III for Ox-01 to Begin in AIS in Early 2025 • Pivotal Trial to Evaluate Novel Adjunct Drug for Mechanical Thrombectomy BARCELONA, Spain, Dec. 5, 2023 /PRNewswire-PRWeb/ -- FreeOx Biotech SL, a late-stage clinical biopharmaceutical company pioneering the development of a...
↧